The effect of pentadecapeptide BPC 157 and high dose diclofenac on induced short bowel syndrome

@inproceedings{Lojo2011TheEO,
  title={The effect of pentadecapeptide BPC 157 and high dose diclofenac on induced short bowel syndrome},
  author={Nermin Lojo and Žarko Ra{\vs}i{\'c} and Marko Bari{\'c} and M. Stephen Sever and Željko Romi{\'c} and Sven Seiwerth and Predrag Sikiric},
  year={2011}
}
Stable gastric pentadecapeptide BPC 157 (an anti-ulcer peptide effective in IBD trials, LD1 not achieved) counteracted short bowel syndrome (Sever et al., Dig Dis Sci, 2009) and protected rats against diclofenac gastrointestinal injuries (Ilic et al., J Physiol Pharmacol, 2009). Aim: In this study we tested the effect of pentadecapeptide 157 on induced short bowel syndrome rats aggravated with high dose of diclofenac. Material and methods We used 80%-small intestine resection and then short… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.

Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.

  • Current pharmaceutical design
  • 2012
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Similar Papers

Loading similar papers…